ALBINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 930
EU - Europa 644
AS - Asia 160
AF - Africa 3
OC - Oceania 2
Totale 1.739
Nazione #
US - Stati Uniti d'America 930
DE - Germania 315
CN - Cina 108
UA - Ucraina 90
GB - Regno Unito 87
RU - Federazione Russa 68
FI - Finlandia 32
HK - Hong Kong 24
SG - Singapore 21
IT - Italia 17
IE - Irlanda 14
BE - Belgio 7
FR - Francia 6
IN - India 4
CZ - Repubblica Ceca 3
AU - Australia 2
RO - Romania 2
BY - Bielorussia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ID - Indonesia 1
JP - Giappone 1
NL - Olanda 1
PL - Polonia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 1.739
Città #
Fairfield 173
Woodbridge 123
Houston 92
Ashburn 67
Seattle 67
Jacksonville 65
Cambridge 50
Wilmington 47
Chandler 42
Ann Arbor 40
Princeton 26
Hong Kong 24
Lancaster 23
Nanjing 23
New York 20
Helsinki 18
Dublin 14
Nanchang 14
Beijing 13
Nürnberg 13
Singapore 11
San Diego 10
Brussels 7
Changsha 7
Tianjin 7
Dearborn 6
Des Moines 6
Shanghai 6
Hebei 5
Shenyang 5
Brescia 4
Jiaxing 4
Ningbo 4
Verona 4
Jinan 3
London 3
Milan 3
Taiyuan 3
Boardman 2
Brno 2
Changchun 2
Hangzhou 2
Kunming 2
Lanzhou 2
Orange 2
Taizhou 2
Washington 2
Abidjan 1
Amsterdam 1
Carhaix 1
Chicago 1
Chiswick 1
Cleveland 1
Clifton 1
Corinella 1
Guangzhou 1
Lappeenranta 1
Los Angeles 1
Minsk 1
Monmouth Junction 1
New Bedfont 1
Olomouc 1
Perth 1
Redmond 1
San Mateo 1
Surabaya 1
Taipei 1
Warsaw 1
Totale 1.091
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 190
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 155
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 152
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 143
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 142
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 136
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 135
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 135
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules. 131
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study 131
Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons 120
Impact of detectable human cytomegalovirus DNAemia on viro-immunologicaleffectiveness of HAART in HIV-infected patients naive to antiretroviral therapy 97
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 91
Reply to van der Pas et al 13
Totale 1.771
Categoria #
all - tutte 6.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020448 0 23 27 69 37 55 57 56 48 51 4 21
2020/2021213 4 39 4 21 14 32 7 23 25 19 18 7
2021/2022143 7 41 0 1 2 1 9 5 5 25 9 38
2022/2023129 13 2 0 3 16 36 0 14 29 1 8 7
2023/2024126 6 6 10 17 7 25 8 3 25 1 0 18
2024/20254 3 1 0 0 0 0 0 0 0 0 0 0
Totale 1.771